- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed/Refractory Systemic Light Chain Amyloidosis in United Kingdom
Total 561 results
-
Ionis Pharmaceuticals, Inc.Active, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
AmgenCompletedRelapsed/Refractory Acute Lymphoblastic LeukemiaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Molecular Templates, Inc.TerminatedRelapsed and/or Refractory Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Gadeta B.V.Active, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Dynavax Technologies CorporationCompletedStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Refractory Pancreatic AdenocarcinomaUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Luminary TherapeuticsThe Cleveland Clinic; Case Western Reserve UniversityRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Ajai ChariCelgene CorporationCompletedMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Roswell Park Cancer InstituteIpsenActive, not recruitingUnresectable Pancreatic Neuroendocrine Carcinoma | Locally Advanced Digestive System Neuroendocrine Carcinoma | Locally Advanced Pancreatic Neuroendocrine Carcinoma | Metastatic Digestive System Neuroendocrine Carcinoma | Metastatic Pancreatic Neuroendocrine Carcinoma | Refractory Digestive... and other conditionsUnited States
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Kura Oncology, Inc.CompletedRelapsed or Refractory Peripheral T-Cell LymphomaUnited States, Spain, Korea, Republic of
-
National Cancer Institute (NCI)CompletedHIV Infection | Clear Cell Renal Cell Carcinoma | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)RecruitingMultiple Myeloma | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Columbia UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingMitochondrial Diseases | Mitochondrial Disorders | Mitochondrial Genetic Disorders | Disorder of Mitochondrial Respiratory Chain Complexes | Deletion and Duplication of Mitochondrial DNAUnited States, Canada
-
Epizyme, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B Cell Lymphoma Refractory | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult... and other conditionsUnited States, Italy
-
Hackensack Meridian HealthJanssen Scientific Affairs, LLC; Genentech, Inc.Active, not recruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
-
Memorial Sloan Kettering Cancer CenterMethylGene Inc.TerminatedLymphoma | Relapsed and Refractory | Diffuse Large B-Cell Lymphoma and Follicular LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumAbbottTerminatedAcute Lymphoblastic Leukemia | Relapsed Pediatric ALL | Recurrent Pediatric ALL | Refractory Pediatric ALLUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Metastatic Pancreatic Carcinoma | Refractory Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer... and other conditionsUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
UNC Lineberger Comprehensive Cancer CenterGenzyme, a Sanofi CompanyRecruitingMultiple Myeloma | Aging | Relapse | Co-morbidity | RefractoryUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Cyclacel Pharmaceuticals, Inc.CompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NovartisActive, not recruitingRefractory Hurthle Cell Thyroid CancerUnited States